Ubs Group Ag A Tyr Pharma Inc Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.42 - $2.02 $5,347 - $7,607	3,766 Added 22.93%	20,192 $39,000
Q4 2023 Feb 09, 2024	BUY	$1.11 - $1.51 $13,349 - $18,160	12,027 Added 273.4%	16,426 $23,000
Q3 2023 Nov 09, 2023	BUY	$1.55 - $2.23 $6,818 - $9,809	4,399 New	4,399 $6,000
Q1 2023 May 12, 2023	BUY	$1.88 - $2.5 $1,880 - $2,500	1,000 New	1,000 $2,000
Q3 2022 Nov 10, 2022	BUY	$2.79 - $4.15 $11,090 - $16,496	3,975 Added 198.75%	5,975 $18,000
Q2 2022 Aug 10, 2022	SELL	$2.63 - $5.61 $5,260 - $11,220	-2,000 Reduced 50.0%	2,000 $6,000
Q1 2022 May 16, 2022	BUY	$4.75 - $7.54 $13,623 - $21,624	2,868 Added 253.36%	4,000 $21,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $8,252 - $10,754	1,132 New	1,132 $8,000
Q3 2021 Nov 15, 2021	SELL	$4.22 - $12.48 $13,352 - $39,486	-3,164 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.62 - $4.88 $11,453 - $15,440	3,164 New	3,164 $15,000
Q4 2020 Feb 11, 2021	SELL	$3.07 - $4.66 $5,025 - $7,628	-1,637 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.23 - $5.39 $124,070 - $207,040	-38,412 Reduced 95.91%	1,637 $5,000
Q2 2020 Jul 31, 2020	BUY	$2.55 - $4.58 $5,227 - $9,389	2,050 Added 5.39%	40,049 $178,000
Q1 2020 May 01, 2020	BUY	$2.17 - $7.06 $74,975 - $243,930	34,551 Added 1002.06%	37,999 $106,000
Q4 2019 Feb 14, 2020	BUY	$3.03 - $4.83 $10,447 - $16,653	3,448 New	3,448 $14,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.